Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: Implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels-Reference-Cited by-同舟云学术

Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: Implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels

Published:2006-06 Issue:3 Volume:60 Page:389-393
ISSN:1323-1316
Container-title:Psychiatry and Clinical Neurosciences
language:en
Short-container-title:Psychiatry Clin Neurosci

Author:

YOSHIMURA REIJI,KANEKO SACHIKO,SHINKAI KOJI,NAKAMURA JUN

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology,Neurology,General Medicine,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1819.2006.01519.x/fullpdf

Reference26 articles.

1. Clinical Predictors of Drug Response in Obsessive-Compulsive Disorder

2. A Controlled Trial of Lithium Augmentation in Fluvoxamine-Refractory Obsessive-Compulsive Disorder

3. A Controlled Comparison of Adjuvant Lithium Carbonate or Thyroid Hormone in Clomipramine-Treated Patients with Obsessive-Compulsive Disorder

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: A meta-analysis;Journal of Psychiatric Research;2022-07

2. Pharmacotherapeutic Strategies and New Targets in OCD;The Neurobiology and Treatment of OCD: Accelerating Progress;2021

3. Pharmacogenetics of anxiety disorders;Neuroscience Letters;2020-05

4. Obsessive-compulsive disorder and growth factors: A comparative review;Behavioural Brain Research;2019-10

5. Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder;Journal of Psychiatric Research;2019-07